303 related articles for article (PubMed ID: 9151906)
1. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
Takano T; Fiore S; Maddox JF; Brady HR; Petasis NA; Serhan CN
J Exp Med; 1997 May; 185(9):1693-704. PubMed ID: 9151906
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
Takano T; Clish CB; Gronert K; Petasis N; Serhan CN
J Clin Invest; 1998 Feb; 101(4):819-26. PubMed ID: 9466977
[TBL] [Abstract][Full Text] [Related]
3. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis.
Hachicha M; Pouliot M; Petasis NA; Serhan CN
J Exp Med; 1999 Jun; 189(12):1923-30. PubMed ID: 10377187
[TBL] [Abstract][Full Text] [Related]
4. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor.
Maddox JF; Hachicha M; Takano T; Petasis NA; Fokin VV; Serhan CN
J Biol Chem; 1997 Mar; 272(11):6972-8. PubMed ID: 9054386
[TBL] [Abstract][Full Text] [Related]
5. Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction.
Fiore S; Serhan CN
Biochemistry; 1995 Dec; 34(51):16678-86. PubMed ID: 8527441
[TBL] [Abstract][Full Text] [Related]
6. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
Fierro IM; Colgan SP; Bernasconi G; Petasis NA; Clish CB; Arita M; Serhan CN
J Immunol; 2003 Mar; 170(5):2688-94. PubMed ID: 12594298
[TBL] [Abstract][Full Text] [Related]
7. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release.
Gronert K; Gewirtz A; Madara JL; Serhan CN
J Exp Med; 1998 Apr; 187(8):1285-94. PubMed ID: 9547339
[TBL] [Abstract][Full Text] [Related]
8. Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases.
Pouliot M; Serhan CN
J Periodontal Res; 1999 Oct; 34(7):370-3. PubMed ID: 10685363
[TBL] [Abstract][Full Text] [Related]
9. Aspirin-triggered 15-epi-lipoxin A4 and stable analogs on lipoxin A4 are potent inhibitors of acute inflammation. Receptors and pathways.
Serhan CN; Takano T; Maddox JF
Adv Exp Med Biol; 1999; 447():133-49. PubMed ID: 10086190
[No Abstract] [Full Text] [Related]
10. Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo.
Goh J; Baird AW; O'Keane C; Watson RW; Cottell D; Bernasconi G; Petasis NA; Godson C; Brady HR; MacMathuna P
J Immunol; 2001 Sep; 167(5):2772-80. PubMed ID: 11509622
[TBL] [Abstract][Full Text] [Related]
11. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells.
Ariel A; Chiang N; Arita M; Petasis NA; Serhan CN
J Immunol; 2003 Jun; 170(12):6266-72. PubMed ID: 12794159
[TBL] [Abstract][Full Text] [Related]
12. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo.
Clish CB; O'Brien JA; Gronert K; Stahl GL; Petasis NA; Serhan CN
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8247-52. PubMed ID: 10393980
[TBL] [Abstract][Full Text] [Related]
13. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.
Gronert K; Martinsson-Niskanen T; Ravasi S; Chiang N; Serhan CN
Am J Pathol; 2001 Jan; 158(1):3-9. PubMed ID: 11141472
[TBL] [Abstract][Full Text] [Related]
14. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.
Serhan CN; Chiang N
ScientificWorldJournal; 2002 Jan; 2():169-204. PubMed ID: 12806051
[TBL] [Abstract][Full Text] [Related]
15. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor.
Fiore S; Maddox JF; Perez HD; Serhan CN
J Exp Med; 1994 Jul; 180(1):253-60. PubMed ID: 8006586
[TBL] [Abstract][Full Text] [Related]
16. An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile.
Schottelius AJ; Giesen C; Asadullah K; Fierro IM; Colgan SP; Bauman J; Guilford W; Perez HD; Parkinson JF
J Immunol; 2002 Dec; 169(12):7063-70. PubMed ID: 12471142
[TBL] [Abstract][Full Text] [Related]
17. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils.
Qiu FH; Devchand PR; Wada K; Serhan CN
FASEB J; 2001 Dec; 15(14):2736-8. PubMed ID: 11687510
[TBL] [Abstract][Full Text] [Related]
18. LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation.
Gewirtz AT; Fokin VV; Petasis NA; Serhan CN; Madara JL
Am J Physiol; 1999 Apr; 276(4):C988-94. PubMed ID: 10199831
[TBL] [Abstract][Full Text] [Related]
19. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation.
Chiang N; Fierro IM; Gronert K; Serhan CN
J Exp Med; 2000 Apr; 191(7):1197-208. PubMed ID: 10748237
[TBL] [Abstract][Full Text] [Related]
20. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.
Chiang N; Takano T; Clish CB; Petasis NA; Tai HH; Serhan CN
J Pharmacol Exp Ther; 1998 Nov; 287(2):779-90. PubMed ID: 9808710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]